Cardiorenal end points in a trial of aliskiren for type 2 diabetes. | NobleID

Main

Mint Work Search Explore Works Knowledge Graph Citation Graph Bibliometrics Receipts

v1

Cardiorenal end points in a trial of aliskiren for type 2 diabetes.

Identifier:nobleid.org/w1/20260526/26F2AC9B

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/26F2AC9B.svg?ark=w1%2F20260526%2F26F2AC9B)](https://nobleid.org/work/w1/20260526/26F2AC9B)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

info@nobleid.org

About FAQ Terms Policy Persistence & Resolver Service Policy